Detalhe da pesquisa
1.
Alteration of PD-L1 (SP142) status after neoadjuvant chemotherapy and its clinical significance in triple-negative breast cancer.
Breast Cancer Res Treat
; 2024 May 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38753066
2.
AZD8186 in Combination With Paclitaxel in Patients With Advanced Gastric Cancer: Results From a Phase Ib/II Study (KCSG ST18-20).
Oncologist
; 28(9): e823-e834, 2023 09 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37036671
3.
The Hospitalist-Oncologist co-ManagemEnt (HOME) system improves hospitalization outcomes of patients with cancer.
BMC Health Serv Res
; 23(1): 1367, 2023 Dec 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38057800
4.
Prognostic role of tumor subtype and germline BRCA mutation in advanced breast cancer patients treated with palbociclib plus endocrine therapy.
Breast Cancer Res Treat
; 196(1): 121-128, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36070058
5.
The prognostic role of soluble transforming growth factor-ß and its correlation with soluble programmed death-ligand 1 in biliary tract cancer.
Liver Int
; 41(2): 388-395, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32780918
6.
Pneumocystis jirovecii pneumonia in diffuse large B-cell Lymphoma treated with R-CHOP.
Mycoses
; 64(1): 60-65, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-32970331
7.
Immunogenicity of Influenza Vaccination in Patients with Cancer Receiving Immune Checkpoint Inhibitors.
Clin Infect Dis
; 71(2): 422-425, 2020 07 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31680143
8.
Identifying germline APOBEC3B deletion and immune phenotype in Korean patients with operable breast cancer.
Breast Cancer Res Treat
; 183(3): 697-704, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32715441
9.
Enhanced antitumor effect of binimetinib in combination with capecitabine for biliary tract cancer patients with mutations in the RAS/RAF/MEK/ERK pathway: phase Ib study.
Br J Cancer
; 121(4): 332-339, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31312030
10.
Immune recurrence score using 7 immunoregulatory protein expressions can predict recurrence in stage I-III breast cancer patients.
Br J Cancer
; 121(3): 230-236, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31292534
11.
Prognostic effects of abnormal DNA damage response protein expression in breast cancer.
Breast Cancer Res Treat
; 175(1): 117-127, 2019 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-30671767
12.
Comparison of quality of life and health behaviors in survivors of acute leukemia and the general population.
Ann Hematol
; 98(10): 2357-2366, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31338572
13.
Identification of a potentially avoidable cardiopulmonary resuscitation in hematology and oncology wards.
BMC Palliat Care
; 18(1): 93, 2019 Nov 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31684934
14.
Post-treatment neutrophil-to-lymphocyte ratio at week 6 is prognostic in patients with advanced non-small cell lung cancers treated with anti-PD-1 antibody.
Cancer Immunol Immunother
; 67(3): 459-470, 2018 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-29204702
15.
Integrated 18F-FDG PET/MRI in breast cancer: early prediction of response to neoadjuvant chemotherapy.
Eur J Nucl Med Mol Imaging
; 45(3): 328-339, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29101445
16.
BGJ398, A Pan-FGFR Inhibitor, Overcomes Paclitaxel Resistance in Urothelial Carcinoma with FGFR1 Overexpression.
Int J Mol Sci
; 19(10)2018 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30326563
17.
Loss of ataxia-telangiectasia-mutated protein expression correlates with poor prognosis but benefits from anthracycline-containing adjuvant chemotherapy in breast cancer.
Breast Cancer Res Treat
; 158(2): 233-41, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27329169
18.
Prognostic impact of AJCC response criteria for neoadjuvant chemotherapy in stage II/III breast cancer patients: breast cancer subtype analyses.
BMC Cancer
; 16: 515, 2016 07 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-27444430
19.
Total costs and clinical outcome of hematopoietic stem cell transplantation in adults with leukemia: comparison between reduced-intensity and myeloablative conditioning.
Clin Transplant
; 29(2): 124-33, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25430486
20.
Epidermal growth factor receptor tyrosine kinase inhibitors vs conventional chemotherapy in non-small cell lung cancer harboring wild-type epidermal growth factor receptor: a meta-analysis.
JAMA
; 311(14): 1430-7, 2014 Apr 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-24715074